AVEO

AVEO Pharmaceuticals, Inc.
AVEO

Overview Fund Activity
Delisted

AVEO was delisted on the 19th of January, 2023.

Back to rankings

77 hedge funds and large institutions have $135M invested in AVEO Pharmaceuticals, Inc. in 2022 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 6 closing their positions.

Holders
77
Holders Change
+21
Holders Change %
+37.5%
% of All Funds
1.33%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
27
Increased
17
Reduced
17
Closed
6
Calls
$3.7M
Puts
$291K
Net Calls
+$3.41M
Net Calls Change
+$641K

Top Buyers

1
RCMNY
1
Rubric Capital Management (New York)
New York
$13.7M
2
GC
2
Globeflex Capital
California
$3.03M
3
EGI
3
EAM Global Investors
California
$1.74M
4
EI
4
EAM Investors
California
$3.13M
5
Invesco
5
Invesco
Georgia
$1.42M

Top Sellers

1
JGC
1
J. Goldman & Co
New York
$5.4M
2
Millennium Management
2
Millennium Management
New York
$1.25M
3
ACM
3
AIGH Capital Management
Maryland
$22.5M
4
SSA
4
Schonfeld Strategic Advisors
New York
$788K
5
WVP
5
Worth Venture Partners
New Jersey
$5.64M
Name Holding Trade Value Shares
Change 		Shares
Change %
WFA
76
West Financial Advisors
Iowa
$1K +$1K +100 New
MOS
77
MGO One Seven
Ohio
$329 – – –
Group One Trading
78
Group One Trading
Illinois
– -$51K -7,706 Closed
SFG
79
Steward Financial Group
Texas
– -$13K -2,000 Closed
LFG
80
Larson Financial Group
Missouri
– -$4K -566 Closed
National Bank of Canada
81
National Bank of Canada
Quebec, Canada
– -$1K -100 Closed
1 2 3
4